SEC Form 4 · accession 0001246360-17-001206
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew W Towse
Officer — SVP and Chief Financial Office
Period of report
Mar 3, 2017
Accepted (ET)
Mar 6, 2017 · 6:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 3, 2017 | M | 9,747 | $0.00 | A | 28,488 | D | |
| Common Stock | Mar 3, 2017 | F | 3,151 | $28.31 | D | 25,337 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock Unit | $0.00 | Mar 3, 2017 | M | 9,747 | D | Mar 3, 2015 | Mar 3, 2017 | Common Stock | 9,747 | 0 | D |